DYAX CORP
Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | |
|---|---|---|---|---|---|---|
| Revenue | $14.1M | $12.0M | $11.5M | $48.7M | $51.4M | $21.6M |
| Operating income | −$3.0M | −$8.5M | −$8.7M | −$24.9M | −$14.2M | −$54.1M |
| Net income | −$5.7M | −$11.2M | −$11.3M | −$34.6M | −$24.5M | −$62.4M |
| Total assets | $217.1M | $134.2M | $55.5M | $83.4M | $92.4M | — |
| Total liabilities | $111.3M | $107.9M | $107.0M | $110.8M | $89.8M | — |
| Equity | $105.8M | $26.3M | −$51.6M | −$27.4M | $2.6M | −$38.6M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 126.1M | 99.5M | 98.8M | 98.8M | 98.5M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- −21.4%
- Net margin
- −40.5%
- Return on equity
- −5.4%
- Return on assets
- −2.6%
- Return on capital (ROCE)
- −1.5%
- Liabilities / assets
- 51.3%
- Debt / equity
- 1.05×
- Book value / share
- $0.84
- Revenue growth (YoY)
- 17.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- -1.66distress
- Accruals / assets
- 1.3%clean
- Beneish M-Score
- -1.75elevated
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Pucci Paolo | Jan 22, 2016 | D | 80,000 | — |
| Migausky George VOfficer — EVP & Chief Financial Officer | Jan 22, 2016 | D | 751,975 | — |
| Cohen Ron | Jan 22, 2016 | D | 133,333 | — |
| Christensen GustavOfficer — CEO and President | Jan 22, 2016 | D | 2.4M | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Shareholder voteJan 22, 2016
- Other material eventDec 11, 2015
- Other material eventDec 2, 2015
- Entered a material agreement · Amended charter or bylaws · Regulation FD disclosureNov 2, 2015
- Results of operationsOct 28, 2015
- Results of operationsJul 29, 2015
- Director / officer change · Shareholder voteMay 14, 2015
- Results of operationsApr 29, 2015
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.